Predicted to enable calcium ion binding activity; extracellular matrix binding activity; and glycosaminoglycan binding activity. Predicted to act upstream of or within several processes, including cellular response to leukemia inhibitory factor; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; and positive regulation of cell-substrate adhesion. Predicted to be located in extracellular region. Orthologous to human SPOCK2 (SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2). [provided by Alliance of Genome Resources, Apr 2022]